{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:58:17Z","timestamp":1791237497504,"version":"4.1.0"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes in Taiwan","doi-asserted-by":"crossref","award":["NHRI-EX-113-11121SC"],"award-info":[{"award-number":["NHRI-EX-113-11121SC"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Science and Technology Council in Taiwan","award":["MOST-110-2636-B-002-017"],"award-info":[{"award-number":["MOST-110-2636-B-002-017"]}]},{"name":"National Taiwan University Center for Advanced Computing and Imaging in Biomedicine","award":["NTU-112L900701"],"award-info":[{"award-number":["NTU-112L900701"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Syst Biol Appl"],"DOI":"10.1038\/s41540-025-00545-7","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T12:17:25Z","timestamp":1751372245000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Temporal analysis of doxorubicin-induced cardiac toxicity and hypertrophy"],"prefix":"10.1038","volume":"11","author":[{"given":"Yu-Te","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Ju","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Wei","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zih-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Ching","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Hong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Yu","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An-Chi","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"545_CR1","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1016\/S0021-9258(17)35746-0","volume":"261","author":"KJ Davies","year":"1986","unstructured":"Davies, K. J. & Doroshow, J. H. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J. Biol. Chem. 261, 3060\u20133067 (1986).","journal-title":"J. Biol. Chem."},{"key":"545_CR2","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1016\/S0021-9258(17)35747-2","volume":"261","author":"JH Doroshow","year":"1986","unstructured":"Doroshow, J. H. & Davies, K. J. Redox cycling of anthracyclines by cardiac mitochondria. II. Formation of superoxide anion, hydrogen peroxide, and hydroxyl radical. J. Biol. Chem. 261, 3068\u20133074 (1986).","journal-title":"J. Biol. Chem."},{"key":"545_CR3","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/0002-9149(92)91393-I","volume":"70","author":"RL Larsen","year":"1992","unstructured":"Larsen, R. L. et al. Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults. Am. J. Cardiol. 70, 73\u201377 (1992).","journal-title":"Am. J. Cardiol."},{"key":"545_CR4","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1002\/1097-0142(19870915)60:6<1213::AID-CNCR2820600609>3.0.CO;2-V","volume":"60","author":"JS Steinberg","year":"1987","unstructured":"Steinberg, J. S., Cohen, A. J., Wasserman, A. G., Cohen, P. & Ross, A. M. Acute arrhythmogenicity of doxorubicin administration. Cancer 60, 1213\u20131218 (1987).","journal-title":"Cancer"},{"key":"545_CR5","doi-asserted-by":"publisher","first-page":"710","DOI":"10.7326\/0003-4819-91-5-710","volume":"91","author":"DD Von Hoff","year":"1979","unstructured":"Von Hoff, D. D. et al. Risk factors for doxorubicin-induced congestive heart failure. Ann. Intern. Med. 91, 710\u2013717 (1979).","journal-title":"Ann. Intern. Med."},{"key":"545_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.jshs.2020.11.009","volume":"10","author":"S Bass-Stringer","year":"2021","unstructured":"Bass-Stringer, S., Tai, C. M. K. & McMullen, J. R. IGF1-PI3K-induced physiological cardiac hypertrophy: implications for new heart failure therapies, biomarkers, and predicting cardiotoxicity. J. Sport Health Sci. 10, 637\u2013647 (2021).","journal-title":"J. Sport Health Sci."},{"key":"545_CR7","doi-asserted-by":"publisher","first-page":"7412","DOI":"10.3390\/ijms21197412","volume":"21","author":"R Romero-Becerra","year":"2020","unstructured":"Romero-Becerra, R., Santamans, A. M., Folgueira, C. & Sabio, G. p38 MAPK pathway in the heart: new insights in health and disease. Int. J. Mol. Sci. 21, 7412 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"545_CR8","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.bbrc.2004.07.121","volume":"322","author":"BJ Wilkins","year":"2004","unstructured":"Wilkins, B. J. & Molkentin, J. D. Calcium-calcineurin signaling in the regulation of cardiac hypertrophy. Biochem. Biophys. Res. Commun. 322, 1178\u20131191 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"545_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s10557-022-07362-8","volume":"37","author":"W Cheng","year":"2023","unstructured":"Cheng, W. et al. NF-\u03baB, a potential therapeutic target in cardiovascular diseases. Cardiovasc. Drugs Ther. 37, 571\u2013584 (2023).","journal-title":"Cardiovasc. Drugs Ther."},{"key":"545_CR10","doi-asserted-by":"publisher","first-page":"482582","DOI":"10.1155\/2015\/482582","volume":"2015","author":"FM Da Cunha","year":"2015","unstructured":"Da Cunha, F. M., Torelli, N. Q. & Kowaltowski, A. J. Mitochondrial retrograde signaling: triggers, pathways, and outcomes. Oxid. Med. Cell. Longev. 2015, 482582 (2015).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"545_CR11","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1016\/j.cmet.2022.10.008","volume":"34","author":"M Picard","year":"2022","unstructured":"Picard, M. & Shirihai, O. S. Mitochondrial signal transduction. Cell Metab. 34, 1620\u20131653 (2022).","journal-title":"Cell Metab."},{"key":"545_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13668-3","volume":"11","author":"I Mart\u00ednez-Reyes","year":"2020","unstructured":"Mart\u00ednez-Reyes, I. & Chandel, N. S. Mitochondrial TCA cycle metabolites control physiology and disease. Nat. Commun. 11, 102 (2020).","journal-title":"Nat. Commun."},{"key":"545_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ceb.2015.02.003","volume":"33","author":"L Shi","year":"2015","unstructured":"Shi, L. & Tu, B. P. Acetyl-CoA and the regulation of metabolism: mechanisms and consequences. Curr. Opin. Cell Biol. 33, 125\u2013131 (2015).","journal-title":"Curr. Opin. Cell Biol."},{"key":"545_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.tox.2010.01.019","volume":"270","author":"RA Carvalho","year":"2010","unstructured":"Carvalho, R. A. et al. Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy. Toxicology 270, 92\u201398 (2010).","journal-title":"Toxicology"},{"key":"545_CR15","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","volume":"126","author":"KB Wallace","year":"2020","unstructured":"Wallace, K. B., Sard\u00e3o, V. A. & Oliveira, P. J. Mitochondrial determinants of doxorubicin-induced cardiomyopathy. Circ. Res. 126, 926\u2013941 (2020).","journal-title":"Circ. Res."},{"key":"545_CR16","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41420-023-01792-5","volume":"10","author":"Y Luan","year":"2024","unstructured":"Luan, Y. et al. Cardiac cell senescence: molecular mechanisms, key proteins and therapeutic targets. Cell Death Discov. 10, 78 (2024).","journal-title":"Cell Death Discov."},{"key":"545_CR17","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.jjcc.2019.05.002","volume":"74","author":"I Shimizu","year":"2019","unstructured":"Shimizu, I. & Minamino, T. Cellular senescence in cardiac diseases. J. Cardiol. 74, 313\u2013319 (2019).","journal-title":"J. Cardiol."},{"key":"545_CR18","doi-asserted-by":"publisher","first-page":"155250","DOI":"10.1016\/j.metabol.2022.155250","volume":"134","author":"SR Brand\u00e3o","year":"2022","unstructured":"Brand\u00e3o, S. R., Carvalho, F., Amado, F., Ferreira, R. & Costa, V. M. Insights on the molecular targets of cardiotoxicity induced by anticancer drugs: a systematic review based on proteomic findings. Metab. Clin. Exp. 134, 155250 (2022).","journal-title":"Metab. Clin. Exp."},{"key":"545_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41420-019-0182-6","volume":"5","author":"KM McSweeney","year":"2019","unstructured":"McSweeney, K. M., Bozza, W. P., Alterovitz, W.-L. & Zhang, B. Transcriptomic profiling reveals p53 as a key regulator of doxorubicin-induced cardiotoxicity. Cell Death Discov. 5, 102 (2019).","journal-title":"Cell Death Discov."},{"key":"545_CR20","doi-asserted-by":"publisher","first-page":"2638","DOI":"10.3390\/ijms20112638","volume":"20","author":"M Adamcova","year":"2019","unstructured":"Adamcova, M., Skarkova, V., Seifertova, J. & Rudolf, E. Cardiac Troponins are Among Targets of Doxorubicin-Induced Cardiotoxicity in hiPCS-CMs. Int. J. Mol. Sci. 20, 2638 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"545_CR21","doi-asserted-by":"publisher","first-page":"e68714","DOI":"10.7554\/eLife.68714","volume":"10","author":"F Grafton","year":"2021","unstructured":"Grafton, F. Deep learning detects cardiotoxicity in a high-content screen with induced pluripotent stem cell-derived cardiomyocytes. eLife 10, e68714 (2021).","journal-title":"eLife"},{"key":"545_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1007\/s10565-008-9070-1","volume":"25","author":"VA Sard\u00e3o","year":"2009","unstructured":"Sard\u00e3o, V. A., Oliveira, P. J., Holy, J., Oliveira, C. R. & Wallace, K. B. Morphological alterations induced by doxorubicin on H9c2 myoblasts: nuclear, mitochondrial, and cytoskeletal targets. Cell Biol. Toxicol. 25, 227\u2013243 (2009).","journal-title":"Cell Biol. Toxicol."},{"key":"545_CR23","doi-asserted-by":"publisher","first-page":"e23054","DOI":"10.1002\/jbt.23054","volume":"36","author":"BP Lohanathan","year":"2022","unstructured":"Lohanathan, B. P., Rathinasamy, B., Huang, C.-Y. & Viswanadha, V. P. Neferine attenuates doxorubicin-induced fibrosis and hypertrophy in H9c2 cells. J. Biochem. Mol. Toxicol. 36, e23054 (2022).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"545_CR24","doi-asserted-by":"publisher","first-page":"H844","DOI":"10.1152\/ajpheart.00182.2015","volume":"309","author":"S Mouli","year":"2015","unstructured":"Mouli, S. et al. The role of frataxin in doxorubicin-mediated cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 309, H844\u201359 (2015).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"545_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-3-030-38315-2_1","volume":"1240","author":"W Zhang","year":"2020","unstructured":"Zhang, W., Borcherding, N. & Kolb, R. IL-1 signaling in tumor microenvironment. Adv. Exp. Med Biol. 1240, 1\u201323 (2020).","journal-title":"Adv. Exp. Med Biol."},{"key":"545_CR26","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1161\/CIRCRESAHA.118.312787","volume":"122","author":"JJ Corbalan","year":"2018","unstructured":"Corbalan, J. J. & Kitsis, R. N. RCAN1\u2013calcineurin axis and the set-point for myocardial damage during ischemia-reperfusion. Circ. Res. 122, 796\u2013798 (2018).","journal-title":"Circ. Res."},{"key":"545_CR27","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1002\/cbin.10290","volume":"38","author":"A Zury\u0144","year":"2014","unstructured":"Zury\u0144, A. et al. Expression of cyclin D1 after treatment with doxorubicin in the HL-60 cell line. Cell Biol. Int. 38, 857\u2013867 (2014).","journal-title":"Cell Biol. Int."},{"key":"545_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00428-8","volume":"8","author":"M Hoogstraat","year":"2022","unstructured":"Hoogstraat, M. et al. Comprehensive characterization of pre- and post-treatment samples of breast cancer reveal potential mechanisms of chemotherapy resistance. NPJ Breast Cancer 8, 60 (2022).","journal-title":"NPJ Breast Cancer"},{"key":"545_CR29","doi-asserted-by":"publisher","first-page":"100512","DOI":"10.1016\/j.jbo.2023.100512","volume":"43","author":"Z Li","year":"2023","unstructured":"Li, Z. et al. Long non-coding RNA PVT1 (PVT1) affects the expression of CCND1 and promotes doxorubicin resistance in osteosarcoma cells. J. Bone Oncol. 43, 100512 (2023).","journal-title":"J. Bone Oncol."},{"key":"545_CR30","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1093\/cvr\/cvab161","volume":"118","author":"MS Chen","year":"2022","unstructured":"Chen, M. S., Lee, R. T. & Garbern, J. C. Senescence mechanisms and targets in the heart. Cardiovasc. Res. 118, 1173\u20131187 (2022).","journal-title":"Cardiovasc. Res."},{"key":"545_CR31","doi-asserted-by":"publisher","first-page":"e1006867","DOI":"10.1371\/journal.pcbi.1006867","volume":"15","author":"A Richelle","year":"2019","unstructured":"Richelle, A., Chiang, A. W. T., Kuo, C.-C. & Lewis, N. E. Increasing consensus of context-specific metabolic models by integrating data-inferred cell functions. PLoS Comput. Biol. 15, e1006867 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"545_CR32","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.lfs.2017.12.015","volume":"194","author":"Z-Y Wang","year":"2018","unstructured":"Wang, Z.-Y., Liu, Y.-Y., Liu, G.-H., Lu, H.-B. & Mao, C.-Y. l-Carnitine and heart disease. Life Sci. 194, 88\u201397 (2018).","journal-title":"Life Sci."},{"key":"545_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCULATIONAHA.121.055801","volume":"145","author":"T Magdy","year":"2022","unstructured":"Magdy, T. et al. Identification of drug transporter genomic variants and inhibitors that protect against doxorubicin-induced cardiotoxicity. Circulation 145, 279\u2013294 (2022).","journal-title":"Circulation"},{"key":"545_CR34","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jaccao.2023.11.008","volume":"6","author":"H Fonoudi","year":"2024","unstructured":"Fonoudi, H. et al. Functional validation of doxorubicin-induced cardiotoxicity-related genes. JACC CardioOncol 6, 38\u201350 (2024).","journal-title":"JACC CardioOncol"},{"key":"545_CR35","doi-asserted-by":"publisher","first-page":"172818","DOI":"10.1016\/j.ejphar.2019.172818","volume":"866","author":"N Prathumsap","year":"2020","unstructured":"Prathumsap, N., Shinlapawittayatorn, K., Chattipakorn, S. C. & Chattipakorn, N. Effects of doxorubicin on the heart: from molecular mechanisms to intervention strategies. Eur. J. Pharm. 866, 172818 (2020).","journal-title":"Eur. J. Pharm."},{"key":"545_CR36","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1139\/cjpp-2019-0566","volume":"98","author":"CJ Oldfield","year":"2020","unstructured":"Oldfield, C. J., Duhamel, T. A. & Dhalla, N. S. Mechanisms for the transition from physiological to pathological cardiac hypertrophy. Can. J. Physiol. Pharm. 98, 74\u201384 (2020).","journal-title":"Can. J. Physiol. Pharm."},{"key":"545_CR37","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1111\/1440-1681.13225","volume":"47","author":"AA Shati","year":"2020","unstructured":"Shati, A. A. Doxorubicin-induces NFAT\/Fas\/FasL cardiac apoptosis in rats through activation of calcineurin and P38 MAPK and inhibition of mTOR signalling pathways. Clin. Exp. Pharm. Physiol. 47, 660\u2013676 (2020).","journal-title":"Clin. Exp. Pharm. Physiol."},{"key":"545_CR38","doi-asserted-by":"publisher","first-page":"603","DOI":"10.3892\/mmr.2013.1554","volume":"8","author":"R-M Guo","year":"2013","unstructured":"Guo, R.-M. et al. Activation of the p38 MAPK\/NF-\u03baB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells. Mol. Med. Rep. 8, 603\u2013608 (2013).","journal-title":"Mol. Med. Rep."},{"key":"545_CR39","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41514-024-00135-7","volume":"10","author":"AN Linders","year":"2024","unstructured":"Linders, A. N. et al. A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and aging. npj Aging 10, 9 (2024).","journal-title":"npj Aging"},{"key":"545_CR40","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1101\/gad.331272.119","volume":"34","author":"MG Vizioli","year":"2020","unstructured":"Vizioli, M. G. et al. Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence. Genes Dev. 34, 428\u2013445 (2020).","journal-title":"Genes Dev."},{"key":"545_CR41","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s44161-024-00507-y","volume":"3","author":"AL Bayer","year":"2024","unstructured":"Bayer, A. L. et al. Cytotoxic T cells drive doxorubicin-induced cardiac fibrosis and systolic dysfunction. Nat. Cardiovasc Res 3, 970\u2013986 (2024).","journal-title":"Nat. Cardiovasc Res"},{"key":"545_CR42","first-page":"17912","volume":"10","author":"V Hidalgo","year":"2023","unstructured":"Hidalgo, V. Co-culture with normal and senescent AC16 cardiomyocytes modulates fibrotic response in primary human ventricular fibroblasts. MicroPubl. Biol 10, 17912 (2023).","journal-title":"MicroPubl. Biol"},{"key":"545_CR43","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1124\/pr.56.2.6","volume":"56","author":"G Minotti","year":"2004","unstructured":"Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. & Gianni, L. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity. Pharm. Rev. 56, 185\u2013229 (2004).","journal-title":"Pharm. Rev."},{"key":"545_CR44","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/nm.4087","volume":"22","author":"PW Burridge","year":"2016","unstructured":"Burridge, P. W. et al. Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity. Nat. Med. 22, 547\u2013556 (2016).","journal-title":"Nat. Med."},{"key":"545_CR45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jaccao.2023.03.012","volume":"5","author":"AN Linders","year":"2023","unstructured":"Linders, A. N. et al. Evaluation of senescence and its prevention in doxorubicin-induced cardiotoxicity using dynamic engineered heart tissues. JACC CardioOncol 5, 298\u2013315 (2023).","journal-title":"JACC CardioOncol"},{"key":"545_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-38986-w","volume":"9","author":"BF Bulten","year":"2019","unstructured":"Bulten, B. F. et al. Cardiac molecular pathways influenced by doxorubicin treatment in mice. Sci. Rep. 9, 2514 (2019).","journal-title":"Sci. Rep."},{"key":"545_CR47","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/S0005-2736(02)00612-0","volume":"1567","author":"S Hrelia","year":"2002","unstructured":"Hrelia, S. et al. Doxorubicin induces early lipid peroxidation associated with changes in glucose transport in cultured cardiomyocytes. Biochim. Biophys. Acta 1567, 150\u2013156 (2002).","journal-title":"Biochim. Biophys. Acta"},{"key":"545_CR48","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.cmet.2020.12.003","volume":"33","author":"AA Cluntun","year":"2021","unstructured":"Cluntun, A. A. et al. The pyruvate-lactate axis modulates cardiac hypertrophy and heart failure. Cell Metab. 33, 629\u2013648.e10 (2021).","journal-title":"Cell Metab."},{"key":"545_CR49","doi-asserted-by":"publisher","first-page":"152852","DOI":"10.1016\/j.tox.2021.152852","volume":"459","author":"SR Brand\u00e3o","year":"2021","unstructured":"Brand\u00e3o, S. R. et al. Exploring the aging effect of the anticancer drugs doxorubicin and mitoxantrone on cardiac mitochondrial proteome using a murine model. Toxicology 459, 152852 (2021).","journal-title":"Toxicology"},{"key":"545_CR50","doi-asserted-by":"publisher","first-page":"4705","DOI":"10.1016\/j.jprot.2012.02.004","volume":"75","author":"S Gratia","year":"2012","unstructured":"Gratia, S. et al. Cardiac phosphoproteome reveals cell signaling events involved in doxorubicin cardiotoxicity. J. Proteom. 75, 4705\u20134716 (2012).","journal-title":"J. Proteom."},{"key":"545_CR51","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/md17010002","volume":"17","author":"CS Yoon","year":"2018","unstructured":"Yoon, C. S. Spinochrome D attenuates doxorubicin-induced cardiomyocyte death via improving glutathione metabolism and attenuating oxidative stress. Mar. Drugs 17, 2 (2018).","journal-title":"Mar. Drugs"},{"key":"545_CR52","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s12012-022-09725-x","volume":"22","author":"K Renu","year":"2022","unstructured":"Renu, K. et al. Exploring the pattern of metabolic alterations causing energy imbalance via ppar\u03b1 dysregulation in cardiac muscle during doxorubicin treatment. Cardiovasc. Toxicol. 22, 436\u2013461 (2022).","journal-title":"Cardiovasc. Toxicol."},{"key":"545_CR53","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","volume":"15","author":"M Nakamura","year":"2018","unstructured":"Nakamura, M. & Sadoshima, J. Mechanisms of physiological and pathological cardiac hypertrophy. Nat. Rev. Cardiol. 15, 387\u2013407 (2018).","journal-title":"Nat. Rev. Cardiol."},{"key":"545_CR54","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1021\/acsomega.0c04677","volume":"6","author":"C Geng","year":"2021","unstructured":"Geng, C. et al. Systematic evaluations of doxorubicin-induced toxicity in rats based on metabolomics. ACS Omega 6, 358\u2013366 (2021).","journal-title":"ACS Omega"},{"key":"545_CR55","first-page":"40","volume":"10","author":"DN Kr\u00fcger","year":"2024","unstructured":"Kr\u00fcger, D. N. et al. Characterization of systolic and diastolic function, alongside proteomic profiling, in doxorubicin-induced cardiovascular toxicity in mice. Cardiooncology 10, 40 (2024).","journal-title":"Cardiooncology"},{"key":"545_CR56","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1536\/ihj.23-302","volume":"65","author":"Y Huyan","year":"2024","unstructured":"Huyan, Y. et al. Single-cell transcriptomic analysis reveals myocardial fibrosis mechanism of doxorubicin-induced cardiotoxicity. Int. Heart J. 65, 487\u2013497 (2024).","journal-title":"Int. Heart J."},{"key":"545_CR57","doi-asserted-by":"publisher","first-page":"103129","DOI":"10.1016\/j.redox.2024.103129","volume":"72","author":"X Li","year":"2024","unstructured":"Li, X. et al. Semaglutide attenuates doxorubicin-induced cardiotoxicity by ameliorating BNIP3-Mediated mitochondrial dysfunction. Redox Biol. 72, 103129 (2024).","journal-title":"Redox Biol."},{"key":"545_CR58","doi-asserted-by":"publisher","first-page":"5107193","DOI":"10.1155\/2020\/5107193","volume":"2020","author":"X Yu","year":"2020","unstructured":"Yu, X. et al. Dexrazoxane protects cardiomyocyte from doxorubicin-induced apoptosis by modulating miR-17-5p. Biomed. Res. Int. 2020, 5107193 (2020).","journal-title":"Biomed. Res. Int."},{"key":"545_CR59","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s11010-018-3450-5","volume":"454","author":"CJ Jong","year":"2019","unstructured":"Jong, C. J., Yeung, J., Tseung, E. & Karmazyn, M. Leptin-induced cardiomyocyte hypertrophy is associated with enhanced mitochondrial fission. Mol. Cell Biochem 454, 33\u201344 (2019).","journal-title":"Mol. Cell Biochem"},{"key":"545_CR60","doi-asserted-by":"crossref","unstructured":"Tadokoro, T. et al. Mitochondria-dependent ferroptosis plays a pivotal role in doxorubicin cardiotoxicity. JCI Insight 5, e132747(2023).","DOI":"10.1172\/jci.insight.169756"},{"key":"545_CR61","doi-asserted-by":"publisher","first-page":"C418","DOI":"10.1152\/ajpcell.00356.2016","volume":"312","author":"G Akolkar","year":"2017","unstructured":"Akolkar, G., Bagchi, A. K., Ayyappan, P., Jassal, D. S. & Singal, P. K. Doxorubicin-induced nitrosative stress is mitigated by vitamin C via the modulation of nitric oxide synthases. Am. J. Physiol., Cell Physiol. 312, C418\u2013C427 (2017).","journal-title":"Am. J. Physiol., Cell Physiol."},{"key":"545_CR62","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1016\/j.bpj.2009.07.029","volume":"97","author":"L Zhou","year":"2009","unstructured":"Zhou, L. et al. Modeling cardiac action potential shortening driven by oxidative stress-induced mitochondrial oscillations in guinea pig cardiomyocytes. Biophys. J. 97, 1843\u20131852 (2009).","journal-title":"Biophys. J."},{"key":"545_CR63","doi-asserted-by":"publisher","first-page":"44735","DOI":"10.1074\/jbc.M302673200","volume":"278","author":"MA Aon","year":"2003","unstructured":"Aon, M. A., Cortassa, S., Marb\u00e1n, E. & O\u2019Rourke, B. Synchronized whole cell oscillations in mitochondrial metabolism triggered by a local release of reactive oxygen species in cardiac myocytes. J. Biol. Chem. 278, 44735\u201344744 (2003).","journal-title":"J. Biol. Chem."},{"key":"545_CR64","doi-asserted-by":"publisher","first-page":"4447","DOI":"10.1073\/pnas.0307156101","volume":"101","author":"MA Aon","year":"2004","unstructured":"Aon, M. A., Cortassa, S. & O\u2019Rourke, B. Percolation and criticality in a mitochondrial network. Proc. Natl. Acad. Sci. USA 101, 4447\u20134452 (2004).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"545_CR65","doi-asserted-by":"publisher","first-page":"e1005214","DOI":"10.1371\/journal.pcbi.1005214","volume":"12","author":"BL de Oliveira","year":"2016","unstructured":"de Oliveira, B. L. & Niederer, S. A biophysical systems approach to identifying the pathways of acute and chronic doxorubicin mitochondrial cardiotoxicity. PLoS Comput Biol. 12, e1005214 (2016).","journal-title":"PLoS Comput Biol."},{"key":"545_CR66","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1016\/j.bpj.2013.11.007","volume":"105","author":"LD Gauthier","year":"2013","unstructured":"Gauthier, L. D., Greenstein, J. L., O\u2019Rourke, B. & Winslow, R. L. An integrated mitochondrial ROS production and scavenging model: implications for heart failure. Biophys. J. 105, 2832\u20132842 (2013).","journal-title":"Biophys. J."},{"key":"545_CR67","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/0005-2728(87)90236-2","volume":"892","author":"K Nicolay","year":"1987","unstructured":"Nicolay, K. & de Kruijff, B. Effects of adriamycin on respiratory chain activities in mitochondria from rat liver, rat heart and bovine heart. Evidence for a preferential inhibition of complex III and IV. Biochim. Biophys Acta 892, 320\u2013330 (1987).","journal-title":"Biochim. Biophys Acta"},{"key":"545_CR68","unstructured":"Ma, Y. et al. ModelingToolkit: A Composable Graph Transformation System For Equation-Based Modeling. https:\/\/docs.sciml.ai\/ModelingToolkit\/stable\/ (2021)."},{"key":"545_CR69","doi-asserted-by":"publisher","first-page":"15","DOI":"10.5334\/jors.151","volume":"5","author":"C Rackauckas","year":"2017","unstructured":"Rackauckas, C. & Nie, Q. Differentialequations.jl\u2014a performant and feature-rich ecosystem for solving differential equations in julia. J. Open Res. Softw 5, 15 (2017).","journal-title":"J. Open Res. Softw"},{"key":"545_CR70","doi-asserted-by":"publisher","first-page":"1634","DOI":"10.1038\/s41592-022-01663-4","volume":"19","author":"M Pachitariu","year":"2022","unstructured":"Pachitariu, M. & Stringer, C. Cellpose 2.0: how to train your own model. Nat. Methods 19, 1634\u20131641 (2022).","journal-title":"Nat. Methods"},{"key":"545_CR71","doi-asserted-by":"publisher","first-page":"e0264496","DOI":"10.1371\/journal.pone.0264496","volume":"17","author":"L Zdrazilova","year":"2022","unstructured":"Zdrazilova, L., Hansikova, H. & Gnaiger, E. Comparable respiratory activity in attached and suspended human fibroblasts. PLoS ONE 17, e0264496 (2022).","journal-title":"PLoS ONE"},{"key":"545_CR72","doi-asserted-by":"publisher","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","volume":"34","author":"S Chen","year":"2018","unstructured":"Chen, S., Zhou, Y., Chen, Y. & Gu, J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34, i884\u2013i890 (2018).","journal-title":"Bioinformatics"},{"key":"545_CR73","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"545_CR74","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"545_CR75","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2014a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169 (2015).","journal-title":"Bioinformatics"},{"key":"545_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"545_CR77","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc Ser. B (Methodol.) 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc Ser. B (Methodol.)"},{"key":"545_CR78","doi-asserted-by":"publisher","first-page":"D808","DOI":"10.1093\/nar\/gks1094","volume":"41","author":"A Franceschini","year":"2013","unstructured":"Franceschini, A. et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 41, D808\u201315 (2013).","journal-title":"Nucleic Acids Res."},{"key":"545_CR79","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res 51, D638\u2013D646 (2023).","journal-title":"Nucleic Acids Res"},{"key":"545_CR80","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102, 15545\u201315550 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"545_CR81","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-15-91","volume":"15","author":"A Rau","year":"2014","unstructured":"Rau, A., Marot, G. & Jaffr\u00e9zic, F. Differential meta-analysis of RNA-seq data from multiple studies. BMC Bioinform. 15, 91 (2014).","journal-title":"BMC Bioinform."},{"key":"545_CR82","doi-asserted-by":"publisher","first-page":"e1007185","DOI":"10.1371\/journal.pcbi.1007185","volume":"15","author":"A Richelle","year":"2019","unstructured":"Richelle, A., Joshi, C. & Lewis, N. E. Assessing key decisions for transcriptomic data integration in biochemical networks. PLoS Comput. Biol. 15, e1007185 (2019).","journal-title":"PLoS Comput. Biol."},{"key":"545_CR83","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.ebiom.2019.04.046","volume":"43","author":"MP Pacheco","year":"2019","unstructured":"Pacheco, M. P. et al. Identifying and targeting cancer-specific metabolism with network-based drug target prediction. EBioMedicine 43, 98\u2013106 (2019).","journal-title":"EBioMedicine"},{"key":"545_CR84","doi-asserted-by":"publisher","first-page":"100040","DOI":"10.1016\/j.crmeth.2021.100040","volume":"1","author":"A Richelle","year":"2021","unstructured":"Richelle, A. et al. Model-based assessment of mammalian cell metabolic functionalities using omics data. Cell Rep. Methods 1, 100040 (2021).","journal-title":"Cell Rep. Methods"},{"key":"545_CR85","doi-asserted-by":"publisher","first-page":"eaaz1482","DOI":"10.1126\/scisignal.aaz1482","volume":"13","author":"JL Robinson","year":"2020","unstructured":"Robinson, J. L. et al. An atlas of human metabolism. Sci. Signal 13, eaaz1482 (2020).","journal-title":"Sci. Signal"},{"key":"545_CR86","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/nbt.4072","volume":"36","author":"E Brunk","year":"2018","unstructured":"Brunk, E. et al. Recon3D enables a three-dimensional view of gene variation in human metabolism. Nat. Biotechnol. 36, 272\u2013281 (2018).","journal-title":"Nat. Biotechnol."},{"key":"545_CR87","doi-asserted-by":"publisher","first-page":"e1004808","DOI":"10.1371\/journal.pcbi.1004808","volume":"12","author":"A Schultz","year":"2016","unstructured":"Schultz, A. & Qutub, A. A. Reconstruction of tissue-specific metabolic networks using CORDA. PLoS Comput. Biol. 12, e1004808 (2016).","journal-title":"PLoS Comput. Biol."},{"key":"545_CR88","doi-asserted-by":"publisher","first-page":"e1003424","DOI":"10.1371\/journal.pcbi.1003424","volume":"10","author":"N Vlassis","year":"2014","unstructured":"Vlassis, N., Pacheco, M. P. & Sauter, T. Fast reconstruction of compact context-specific metabolic network models. PLoS Comput. Biol. 10, e1003424 (2014).","journal-title":"PLoS Comput. Biol."},{"key":"545_CR89","doi-asserted-by":"publisher","first-page":"e1000082","DOI":"10.1371\/journal.pcbi.1000082","volume":"4","author":"SA Becker","year":"2008","unstructured":"Becker, S. A. & Palsson, B. O. Context-specific metabolic networks are consistent with experiments. PLoS Comput. Biol. 4, e1000082 (2008).","journal-title":"PLoS Comput. Biol."},{"key":"545_CR90","doi-asserted-by":"publisher","first-page":"e1000489","DOI":"10.1371\/journal.pcbi.1000489","volume":"5","author":"C Colijn","year":"2009","unstructured":"Colijn, C. et al. Interpreting expression data with metabolic flux models: predicting Mycobacterium tuberculosis mycolic acid production. PLoS Comput. Biol. 5, e1000489 (2009).","journal-title":"PLoS Comput. Biol."},{"key":"545_CR91","doi-asserted-by":"publisher","first-page":"e1007099","DOI":"10.1371\/journal.pcbi.1007099","volume":"16","author":"ML Jenior","year":"2020","unstructured":"Jenior, M. L., Moutinho, T. J., Dougherty, B. V. & Papin, J. A. Transcriptome-guided parsimonious flux analysis improves predictions with metabolic networks in complex environments. PLoS Comput. Biol. 16, e1007099 (2020).","journal-title":"PLoS Comput. Biol."},{"key":"545_CR92","doi-asserted-by":"publisher","DOI":"10.1186\/1752-0509-7-74","volume":"7","author":"A Ebrahim","year":"2013","unstructured":"Ebrahim, A., Lerman, J. A., Palsson, B. O. & Hyduke, D. R. COBRApy: COnstraints-Based Reconstruction and Analysis for Python. BMC Syst. Biol. 7, 74 (2013).","journal-title":"BMC Syst. Biol."},{"key":"545_CR93","doi-asserted-by":"publisher","unstructured":"Li, F. et al. Deep learning-based kcat prediction enables improved enzyme-constrained model reconstruction. Nat. Catal. https:\/\/doi.org\/10.1038\/s41929-022-00798-z (2022).","DOI":"10.1038\/s41929-022-00798-z"},{"key":"545_CR94","doi-asserted-by":"publisher","first-page":"100640","DOI":"10.1016\/j.mcpro.2023.100640","volume":"22","author":"Q Huang","year":"2023","unstructured":"Huang, Q., Szklarczyk, D., Wang, M., Simonovic, M. & von Mering, C. Paxdb 5.0: curated protein quantification data suggests adaptive proteome changes in yeasts. Mol. Cell Proteom. 22, 100640 (2023).","journal-title":"Mol. Cell Proteom."},{"key":"545_CR95","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s41596-023-00931-7","volume":"19","author":"Y Chen","year":"2024","unstructured":"Chen, Y. et al. Reconstruction, simulation and analysis of enzyme-constrained metabolic models using GECKO Toolbox 3.0. Nat. Protoc. 19, 629\u2013667 (2024).","journal-title":"Nat. Protoc."},{"key":"545_CR96","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/9384318","volume":"2021","author":"E Badr","year":"2021","unstructured":"Badr, E., Abdul Salam, M., Almotairi, S. & Ahmed, H. From linear programming approach to metaheuristic approach: scaling techniques. Complexity 2021, 1\u201310 (2021).","journal-title":"Complexity"},{"key":"545_CR97","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/msb.2010.47","volume":"6","author":"NE Lewis","year":"2010","unstructured":"Lewis, N. E. et al. Omic data from evolved E. coli are consistent with computed optimal growth from genome-scale models. Mol. Syst. Biol. 6, 390 (2010).","journal-title":"Mol. Syst. Biol."},{"key":"545_CR98","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.21105\/joss.01026","volume":"3","author":"R Vallat","year":"2018","unstructured":"Vallat, R. Pingouin: statistics in Python. J. Open Source Softw. 3, 1026 (2018).","journal-title":"J. Open Source Softw."},{"key":"545_CR99","doi-asserted-by":"publisher","first-page":"W398","DOI":"10.1093\/nar\/gkae253","volume":"52","author":"Z Pang","year":"2024","unstructured":"Pang, Z. et al. MetaboAnalyst 6.0: towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 52, W398\u2013W406 (2024).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Systems Biology and Applications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00545-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00545-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:06:11Z","timestamp":1751375171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41540-025-00545-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["545"],"URL":"https:\/\/doi.org\/10.1038\/s41540-025-00545-7","relation":{},"ISSN":["2056-7189"],"issn-type":[{"value":"2056-7189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}